Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002. Meyers G, Hamadani M, Martens M, Ali H, et al. Bone Marrow Transplant 2023;58:1416-1418.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meyers G, Hamadani M, Martens M, Ali H, et al. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002. Bone Marrow Transplant 2023;58:1416-1418.
PMID: 37749187